胚胎干细胞、成体干细胞、肿瘤干细胞、间充质干细胞与 iPSCs（含 iPSC 衍生细胞），配套专用培养基与诱导方案。 共 669 个产品。
Human iPSC From Blood–Rigid Spine Muscular Dystrophy 1 provides an integration-free disease model for SEPN1-related myopathy and therapeutic testing.
This iPS cell line is derived from a Turner Syndrome donor's blood, reprogrammed using Sendai virus.
Human iPSC From Fibroblast-Alagille Syndrome 1 provides an in vitro model for studying genetic disorders and disease modeling in Alagille syndrome.
Human iPSC From Fibroblast-Alzheimer Disease provides patient-derived stem cells for modeling neurodegeneration and screening potential therapeutics.
Human iPSC From Fibroblast-Canavan Disease ,Patient-derived iPSCs for modeling Canavan disease, ASPA deficiency, and neurodegenerative mechanisms.
Enhance Human iPSC From Fibroblast-Ceroid Lipofuscinosis from ImmunoClone, a neuronal model enabling studies of CLN2 gene, late infantile type, and pathology.
Human iPSC From Fibroblast-Charcot-Marie-Tooth Disease provides patient-derived iPSCs for disease modeling, drug screening, and regenerative research.
Human iPSC From Fibroblast-Choroideremia serves as a disease-specific model for retinal degeneration, ideal for drug discovery and gene therapy research.
Uncover the significance of human iPSC from fibroblasts in Cockayne Syndrome Type A. Engage with pioneering research and explore new therapeutic pathways.
Human iPSC From Fibroblast-Developmental and Epileptic Encephalopathy 2 ,iPSC model with CDKL5 mutation for epilepsy and neurodevelopmental research.
Human iPSC From Fibroblast-Diabetes Mellitus, Juvenile-Onset Insulin-Dependent ,High-quality iPSC from juvenile insulin-dependent diabetes fibroblasts.
HighQC™ Human iPSC From Fibroblast-Epidermolysis Bullosa offers patient-derived models for dystrophic, junctional, and simplex type EB disease studies.
Human iPSC From Fibroblast-FOP enables modeling of fibrodysplasia ossificans progressiva and related bone disorders in pluripotent stem cells.
Human iPSC From Fibroblast-GLUT1 Deficiency Syndrome 1 offers a patient-specific model for studying glucose transporter defects and therapies.
Human iPSC From Fibroblast-Glycogen Storage Disease II ,Fibroblast-derived iPSCs for Glycogen Storage Disease II (Pompe) research and therapeutic studies.
Human iPSC From Fibroblast-Hurler Syndrome ,Patient-derived iPSC line for Hurler Syndrome, supporting IDUA deficiency, lysosomal storage research.
Human iPSC From Fibroblast-Isogenic Control Congenital Disorder Of Deglycosylation ,Fibroblast iPSCs for CDDG, NGLY1, glycosylation and therapy studies.
Human iPSC From Fibroblast-Isogenic Control GLUT1 Deficiency Syndrome 1 ,iPSC for modeling GLUT1DS1 and studying glucose transport and metabolic disorders.
HighQC™ Human iPSC From Fibroblast-Isogenic Control, Congenital Disorder Of Deglycosylation provides reliable disease-specific models for CDDG studies.
Fibroblast-derived iPSC isogenic control for cystic fibrosis supports CFTR studies, disease modeling, drug testing, and personalized medicine research.
Human iPSC From Fibroblast-Isogenic Control provides iPSCs for disease modeling, drug discovery, and regenerative medicine research applications.
Human iPSC From Fibroblast-Isogenic Control, LQTS2 model for cardiac electrophysiology, ion channel research, and personalized therapy development.
Human iPSC From Fibroblast-Isogenic Control, Rett Syndrome, Congenital Variant offers matched genetic controls for neurological and therapeutic studies.
Human iPSC From Fibroblast-Isogenic Control, Tay-Sachs Disease for modeling neurodegeneration, GM2 gangliosidosis, and lysosomal storage diseases.
共 669 个产品 ｜ 第 26 / 28 页
